Rho-kinase inhibitors in the treatment of erectile dysfunction

Author： Rees R.   Cellek S.   Moncaca S.   Ralph D.  

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.1, Iss.1, 2002-01, pp. : 65-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Introduction: Advances in the Treatment of Erectile Dysfunction

By Giuliano F.  

European Urology Supplements, Vol. 1, Iss. 8, 2002-11 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

The Role of Apomorphine SL in the Treatment of Erectile Dysfunction

By Montorsi F.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 4-11

Elsevier

Access to resources Recommend Favorite

Treatment of erectile dysfunction with sildenafil - therapy health outcomes

By Marks L.S.   Duda C.   Dorey F.J.   Macairan M.L.   Santos P.B.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 19-24

Elsevier

Access to resources Recommend Favorite

Pelvic venoablation with ethanol for the treatment of erectile dysfunction due to veno-occlusive dysfunction

By Miwa Y.   Shioyama R.   Itou Y.   Kanamaru H.   Okada K.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 76-79

Elsevier

Access to resources Recommend Favorite

Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis

By Murata T.   Arii S.   Mori A.   Imamura M.  

Journal of Surgical Research, Vol. 114, Iss. 1, 2003-09 ,pp. : 64-71

Elsevier

Access to resources Recommend Favorite